Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
IL27RA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RBCK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM120B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IRS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HLA-C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CDK10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
N4BP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM231 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SPECC1L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PLEKHM2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARNTL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LRRC28 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EFHC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RBBP7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
WIPF2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C10orf10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ATP6V1D - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NRTN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC23A2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LAMP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on